Budapest, Hungary

Katalin Pik

This inventor holds 2 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Katalin Pik: Innovator in Antidepressant Compounds

Introduction

Katalin Pik is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds with potential antidepressant properties. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Katalin Pik holds 2 patents related to compounds with an ergoline skeleton. Her latest patents include formulations that feature new compounds of the general formula (I), where R can be a hydrogen or methyl group. These compounds are prepared by acylating a compound of the general formula (II) with a C6-12 carboxylic acid or a C6-12 carboxylic acid halide. The new compounds and their acid addition salts are designed to be used as antidepressants and antiserotonin agents with prolonged effects.

Career Highlights

Katalin Pik is associated with Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company in Hungary. Her work at this institution has been pivotal in the research and development of innovative therapeutic solutions. She has demonstrated a strong commitment to improving mental health treatments through her research.

Collaborations

Katalin has collaborated with notable colleagues such as Lajos Wolf and Endre Csanyi. These partnerships have enriched her research and contributed to the successful development of her patented compounds.

Conclusion

Katalin Pik is a remarkable inventor whose work in developing antidepressant compounds has the potential to make a significant impact in the field of mental health. Her contributions reflect her dedication to innovation and the advancement of pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…